Survival analysis of patients with primary gallbladder cancer from 2010 to 2015 A retrospective study based on SEER data
Zhu, Xiaolei1; Zhang, Xiaochang1; Hu, Xiao2; Ren, Hongyan3; Wu, Shenghui4; Wu, Jing5; Wu, Guoyi6; Si, Xiang1; Wang, Baohua5
刊名MEDICINE
2020-10-02
卷号99期号:40页码:6
关键词primary gallbladder cancer prognosis survival
ISSN号0025-7974
DOI10.1097/MD.0000000000022292
通讯作者Wu, Jing(wujingcdc42@163.com) ; Wu, Guoyi()
英文摘要This study aims to assess the survival status of patients with Primary gallbladder cancer (PGC) and analyze the prognosis factors to facilitate the exploration of the prevention and therapeutic strategies of PGC. Data from 2433 PGC patients collected from 2010 to 2015 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. The SEER*Stat, SPSS 23.0 and GraphPad Prism 8 were used for statistical analyses. Kaplan Meier analysis was performed for the survival curve, log-rank test analyses were used to compare the survival rate difference and Cox regression analyses were performed to determine the prognosis factors. A total of 2433 PGC cases were reported from 2010 to 2015. The median age was 64.2 +/- 10.4 years old and the percentages of the white patients were 73.7% (1794/2433). The percentage of patients who received surgery treatment was 82.1% (1998/2433). The overall median survival time of all patients was 19 months and the 5-year survival rate was 28.8%. The 5-year survival rate of PGC patients in pN2 stage dropped to 0% and the 5-year survival rate for PGC patients with distant metastasis was only 2.7%. Age, tumor size, grade, pT stage, pM stage were risk factors for prognosis, surgery or not and radiation or not were protective factors for prognosis. Survival analysis of PGC patients based on the SEER database have provided an opportunity for understanding PGC prognosis and the basis for the exploration of viable PGC prevention and therapeutic strategies.
资助项目National Key Research and Development Program of Ministry of Science and Technology of China[2016YFC1302600] ; Integrated Cancer Prevention and Control in the Huai River Program
WOS关键词RISK
WOS研究方向General & Internal Medicine
语种英语
出版者LIPPINCOTT WILLIAMS & WILKINS
WOS记录号WOS:000579119300026
资助机构National Key Research and Development Program of Ministry of Science and Technology of China ; Integrated Cancer Prevention and Control in the Huai River Program
内容类型期刊论文
源URL[http://ir.igsnrr.ac.cn/handle/311030/157117]  
专题中国科学院地理科学与资源研究所
通讯作者Wu, Jing; Wu, Guoyi
作者单位1.Chinese Ctr Dis Control & Prevent, Off Noncommunicable Dis Control & Aging Hlth, Beijing, Peoples R China
2.Beijing Ctr Dis Control & Prevent, Informat Ctr, Beijing, Peoples R China
3.Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China
4.Univ Texas Hlth San Antonio, Dept Epidemiol & Biostat, San Antonio, TX USA
5.Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, 27 Nanwei Rd, Beijing, Peoples R China
6.Fudan Univ, Shanghai Publ Hlth Clin Ctr, 2901 Caolang Rd, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Zhu, Xiaolei,Zhang, Xiaochang,Hu, Xiao,et al. Survival analysis of patients with primary gallbladder cancer from 2010 to 2015 A retrospective study based on SEER data[J]. MEDICINE,2020,99(40):6.
APA Zhu, Xiaolei.,Zhang, Xiaochang.,Hu, Xiao.,Ren, Hongyan.,Wu, Shenghui.,...&Wang, Baohua.(2020).Survival analysis of patients with primary gallbladder cancer from 2010 to 2015 A retrospective study based on SEER data.MEDICINE,99(40),6.
MLA Zhu, Xiaolei,et al."Survival analysis of patients with primary gallbladder cancer from 2010 to 2015 A retrospective study based on SEER data".MEDICINE 99.40(2020):6.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace